• Contact Us
  • Careers
Sound Pharmaceuticals
  • Team
    • Leadership
    • Board of Directors
    • Advisors
  • Neurotology
  • Technology
  • Pipeline
  • News
Jun 25
Love0

Sound Pharmaceuticals announces positive topline results from the SPI-1005 Phase 2b Meniere’s Disease clinical trial

By Jim News Short

SPI-1005 hits pre-specified endpoints resulting in a significant improvement in hearing loss of 65% and 95% relative to placebo

Read More

Mar 20
Love0

Sound Pharmaceuticals announces completion of patient enrollment in the Phase 2b Meniere’s Disease clinical trial

By Jim News Short

Read More

Jan 14
Love0

Sound Pharmaceuticals advances Phase 2 hearing loss clinical trial in Cystic Fibrosis

By Jim News Short

Read More

Oct 18
Love0

Sound Pharmaceuticals to Present Preliminary Data on Ototoxicity Study

By Jim News Short

Read More

Nov 01
Love0

University of Oxford and Sound Pharmaceuticals begin Phase 2 clinical trial on novel treatment for bipolar disorder

By Jim News Short

Read More

Oct 03
Love0

Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Meniere’s Disease

By Jim News Short

Read More

Sep 29
Love0

Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by Antibiotics

By Jim News Short

Read More

Jun 29
Love0

Sound Pharmaceuticals completes enrollment on Meniere’s Disease clinical trial

By Jim News Short

Read More

Mar 20
Love0

Sound Pharmaceuticals announces $1.6 Million Award from Cystic Fibrosis Foundation Therapeutics to prevent and treat the hearing loss and tinnitus associated with antibiotic use

By Jim News Short

Read More

Nov 01
Love0

Sound Pharmaceuticals announces two new executive hires to accelerate its Meniere’s drug development program

By Jim Home Page, Uncategorized

Seattle, WA

Sound Pharmaceuticals, a pioneer in the development of novel drug treatments for inner ear disease, announces the hiring of two senior executives. Paul Hoskins, Senior Director of Clinical Operations and G. Michael Wall, PhD, Senior Director of Pharmaceutical Development joined the company this past month. Read More

Previous 1 2 3 4 … 6 Next

Archives

Contact Us

Address:

4010 Stone Way N # 120
Seattle, WA 98103

Phone:

(206) 634-2559

Email:

info@soundpharma.com

Disclosures

Legal & Terms

Other resources

Links
High-Res Logo

All Rights Reserved, Sound Pharmaceuticals.

  • Team
    • Leadership
    • Board of Directors
    • Advisors
  • Neurotology
  • Technology
  • Pipeline
  • News
  • Contact Us
  • Careers